NCT06180369

Clinical Efficacies of Different Agents in Molar-Incisor Hypomineralization

Evaluation of Clinical Efficacies of Different Agents in Molar-Incisor Hypomineralization-Affected Molars

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Marmara University · Academic / Other
• Sex: All
• Age: 8 Years – 13 Years
• Healthy volunteers: Accepted

Summary

This study aims to assess the clinical effectiveness of GC Fuji Triage ® (GC America Inc., Alsip, Illinois) and BeutiSealant (Shofu, Kyoto, Japan) in children aged 8-13 with multiple molars affected by Molar-Incisor Hypomineralization (MIH). The comparison focuses on permanent first molars affected by MIH.

Detailed description

The study targets children within the specified age range with MIH-affected molars, comparing the clinical outcomes of GC Fuji Triage and BeutiSealant. The assessment will provide valuable insights into the efficacy of these agents in managing severe hypomineralization, contributing to our understanding of effective treatment modalities for MIH. The evaluation criteria include restoration success, prevention of further decay development, prevention of post-eruption breakdown, alleviation of tooth sensitivity, and measurement of life quality. These criteria will be compared with those of Resin Fissure Sealant.

Conditions

• Molar-Incisor Hypomineralization

Interventions

Type	Name	Description
OTHER	GC Fuji Triage ® GC America Inc., Alsip, Illinois )	Fissur Sealent application
OTHER	BeutiSealant (Shofu, Kyoto, Japonya)	Fissur Sealent application

Timeline

• Start date: 2023-12-01
• Primary completion: 2024-12-01
• Completion: 2025-05-01
• First posted: 2023-12-22
• Last updated: 2023-12-22